Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Spinal cord & DRG stimulation · Nevada | Spinal cord & DRG stimulation · California | |
|---|---|---|
| Surgeons, 2024 | 6 | 48 |
| Medicare fee-for-service cases | 353 | 1,564 |
| Growth since 2019 (Medicare FFS) | −6%/yr | −4.8%/yr |
| Forecast cases (Medicare FFS) | 380 in 2030 | 1,890 in 2030 |
| Forecast growth | +1%/yr to 2030 | +3.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.1 | 0.4 |
| Medicare Advantage share | 56% | 56% |
| Out of hospital | 95% (+23 pts since 2019) | 89% (+17 pts since 2019) |
| Cases per surgeon | 59 | 33 |
| Top 10 surgeons' share | 100% | 42% |
| Surgeons growing | 1 | 2 |
| New since the base year | 0 | 6 |
| Likely to stop billing it | 0 by 2026 | 18 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $42K | $39K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.